Bloom for Skin

Besides An Essential Skin Care Ingredient, Bloom Can Do More!

• 2023-07-26
  

  How to Bloom Gelatin: A Comprehensive Guide

  Welcome to this FAQ guide on how to bloom gelatin! Whether you're an aspiring home cook, a culinary enthusiast, or a professional chef, understanding the process of blooming gelatin is essential for achieving optimal results in your recipes. In this comprehensive FAQ, we will cover all aspects of blooming gelatin, from its purpose to the step-by-step procedure. Let's dive in!
  Gelatin
• 2026-01-02
  

  Alipay, Baidu, and iFlytek Win Big—As the Government Spends $1.1 Billion on AI Healthcare, Is This a Lifeline or a Feeding Frenzy for Tech Giants?

  Spring may have finally arrived for AI healthcare—but the first things to bloom might not be flowers, but grass: the quiet, resilient, soil-ready pioneers waiting for real ground to grow.
• 2024-12-17
  

  Gevo and LG Chem Extend Bio-Propylene Agreement

  "Gevo's collaboration with LG Chem is an excellent example of how we intend to accelerate the development and commercialization of our patented ETO technology to enable renewable chemicals with our world-class partners," said Dr. Paul Bloom, Gevo’s Chief Carbon and Innovation Officer. "Our ETO process has the potential to decarbonize a significant portion of the propylene market, and LG Chem is beginning commercial activities ahead of schedule, which is earlier than our initially planned timeline."
  Gevo LG chem
• 2024-09-05
  

  Volkswagen May Close Two German Plants, Union Angrily Criticizes 'Shaking the Foundation', Stock Price Rises 1.25% Against the Trend!

  According to the CCTV news channel reported on September 3, Volkswagen Group solemnly announced on September 2 local time that it is carefully evaluating the possibility of closing a vehicle manufacturing plant and a parts plant in Germany for the first time. The move, if implemented, would be the first time in Volkswagen's history that it has closed a plant in Germany. Foreign media reported that once the news was disclosed, it was immediately resolutely opposed by the trade union, Germany's top industrial federation IG Metall expressed severe criticism of the plan, arguing that it "shakes the foundation of the automaker." "The European automotive industry is facing a serious and urgent situation," Volkswagen Group Chief Executive Oliver Blum said in a written statement. Mr Bloom stressed: "The economic environment is becoming increasingly difficult and new competitors are constantly entering the European market. In particular, Germany, a manufacturing base, is falling behind in terms of competitiveness. Therefore, the leadership of the Volkswagen Group believes that decisive measures must be taken now. Volkswagen Group said its brands would face a "comprehensive restructuring" and made clear that the current situation meant the closure of vehicle production and parts plants could not be ruled out.
• 2024-09-02
  

  Hengrui Pharmaceuticals: The Innovation Dilemma Behind the €160 Million Windfall, as the Supercarrier Struggles to Escape the Shadow of the Old Way

  BeiGene, its half-year revenue has exceeded the 10 billion mark, reaching 11.996 billion yuan, an increase of 65.4%; The net loss attributable to shareholders of the parent company was 2.877 billion yuan, a decrease of 45% year-on-year. Crucially, BeiGene has finally hit the break-even point after years of losses. After long-term research and development investment, BeiGene also ushered in the dawn of profitability. At the same time, with its dazzling half-year performance report, Fosun Pharma achieved an operating income of 20.463 billion yuan and a net profit of 1.254 billion yuan, and its international market expansion of biosimilars was in full bloom, which was dubbed as "the first brother of globalization" by some media reports. In the highly competitive field of innovative drugs, emerging innovative drug companies are like well-equipped and agile destroyers. However, despite the slow turn of the carrier, it has the advantage of being "big". First of all, Hengrui Pharmaceutical is still the strongest clinical execution of pharmaceutical companies in China, even if its research and development pipeline into the clinical stage late, still can rely on its excellent clinical execution ability. For example, in the research and development of PCSK9 monoclonal antibody, Hengrui Pharmaceutical only took 62 months from research application to listing declaration, which is far faster than other companies that started earlier. On the other hand, it is well known that drug development requires three "10" challenges: a 10-year development cycle, a billion dollars of investment, and a 10% success rate in clinical trials. As a result, revenue-driven profit growth is often seen as a sign of greater strength. In the first half of the year, a total of 57 innovative drug clinical approvals were obtained, of which 10 clinical trials were advanced to phase III, 20 to phase II, 19 to phase I, while more than 90 drugs are in clinical development stage, and more than 300 clinical trials are carried out worldwide.
• 2024-08-06
  

  EU Evaluates Safety and Efficacy of Caraway Oil as Animal Feed Additive

  EFSA's evaluation report on the safety and effectiveness of caraway oil as an animal feed additive not only provides valuable scientific basis and guidance recommendations for the industry and beyond, but also further promotes the in-depth research and development in the field of food safety and animal health. We have reason to believe that in the future with the continuous progress of science and technology and the continuous improvement of people's cognitive level, caraway oil, an ancient and magical herbal essence, will bloom more brilliant light in more fields.